Shimadzu expands mammography efforts

Article

Shimadzu Medical Systems officially moved into the global mammography market at the RSNA show when it signed a nonexclusive distribution and marketing agreement with Planmed. According to terms of the deal, Wood Dale, IL-based Planmed’s Sophie and

Shimadzu Medical Systems officially moved into the global mammography market at the RSNA show when it signed a nonexclusive distribution and marketing agreement with Planmed. According to terms of the deal, Wood Dale, IL-based Planmed’s Sophie and Sophie Classic product line will be sold worldwide under Shimadzu’s own name. The agreement expands a partnership established in 1995 between Planmed and Shimadzu Corporation, which allows Shimadzu to market Planmed’s mammography products in Japan under the trade name Sepio. The new agreement extends Shimadzu’s distribution of Planmed mammography products to North and South America, Europe, and Australia.

The deal allows Shimadzu to fill out its product portfolio and target larger strategic accounts such as group purchasing and veterans organizations and hospital networks, according to Don Karle, director of sales and marketing for North America. The Torrance, CA-based firm plans to sell between 30 and 50 mammography units in 2000, Karle said.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.